Keyphrases
Chronic Lymphocytic Leukemia
100%
Hypomethylating Agents
100%
Cancer-testis Antigen
100%
Immunogenic Tumor
100%
Antigen Presentation
40%
Tolerogenic
40%
Cancer Cells
20%
CD40
20%
Costimulatory Molecules
20%
Quantitative PCR
20%
CD80
20%
Immunogenicity
20%
Specificity Protein 1
20%
Demethylating Agents
20%
Antigen Expression
20%
Specific Antibodies
20%
Chronic Lymphocytic Leukemia Cells
20%
CD86
20%
Aberrant Expression
20%
MHC Molecules
20%
Cancer-specific
20%
Leukemia Cell Lines
20%
5-aza-2′-deoxycytidine
20%
Western Blot
20%
Malignant B Cells
20%
Immunotherapeutics
20%
Patient Cells
20%
Solid Malignancies
20%
Immunotherapy Targets
20%
Active Immunization
20%
Two-pronged Approach
20%
Biochemistry, Genetics and Molecular Biology
Antigen Presentation
100%
Cancer Cell
50%
B Cell
50%
Reverse Transcription Polymerase Chain Reaction
50%
CD80
50%
Demethylating Agent
50%
Decitabine
50%
CD86
50%
Immunogenicity
50%
Antigen Expression
50%
Western Blot
50%
Immunology and Microbiology
Cancer Testis Antigen
100%
Antigen Presentation
66%
B Cell
33%
ELISA
33%
Reverse Transcription Polymerase Chain Reaction
33%
Western Blot
33%
CD80
33%
Cancer Cell
33%
Immunogenicity
33%
Antigen Expression
33%
CD86
33%
Active Immunotherapy
33%
Leukemia Cell Line
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
100%
Cancer Testis Antigen
100%
Malignant Neoplasm
50%
Enzyme-Linked Immunosorbent Assay
16%
Western Blot
16%
RNA Directed DNA Polymerase
16%
Immunotherapy
16%
Decitabine
16%
Immunogenicity
16%